Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-29

FDA Approved: VUMERITY — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Biogen's VUMERITY (diroximel fumarate). The approval updates the product's labeling to reflect the changes approved …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VUMERITY (diroximel fumarate)

Snippet

SUPPL AP for VUMERITY (DIROXIMEL FUMARATE)